Lv1
48 积分 2024-05-25 加入
Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial
1小时前
待确认
Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer
1个月前
已完结
The Impact of Ultracentral Tumor Location on Outcomes in Patients with Pulmonary Oligometastases: A Secondary Analysis of the Single-Arm Phase 2 SABR-5 Trial
1个月前
已完结
Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation
1个月前
已完结
PT2.13.01 A Phase II Trial of Induction Camrelizumab Plus Chemotherapy Followed by Chemoradiotherapy and Consolidation in Limited-Stage SCLC
3个月前
已完结
The Diverse Roles of Lipid Metabolism Reprogramming in Shaping the Tumor Immune Microenvironment
3个月前
已完结
Local Single-Dose Radiation Improves Adoptive Cell Therapy With Tumor-Infiltrating Lymphocytes
7个月前
已关闭
Treatment of NSCLC after chemoimmunotherapy — are we making headway?
7个月前
已完结
A novel EST‐derived RNAi screen reveals a critical role for farnesyl diphosphate synthase in β2‐adrenergic receptor internalization and down‐regulation
9个月前
已完结
Artificial intelligence predicts lung cancer radiotherapy response: A meta-analysis
11个月前
已完结
皖公网安备34019202002308
